Brustimplantat assoziiertes ALCL: ab wann musste aufgeklärt werden?
Abstract
Abstract: Currently, there is a growing number of lawsuits from patients, primarily those with Biocell breast implants, against the surgeons who performed the procedures. This is partly due to law firms actively seeking out affected individuals to pursue claims for damages based on allegedly inadequate disclosure of the risk of BIA-ALCL. The unsuccessful attempts to obtain financial compensation through product liability and proof of a defective medical device may also contribute to this trend. This raises the question of when a surgeon could reasonably be expected to disclose the associated risks.
Fields of Study & Subjects
Medical and Health Sciences Research
Digitalization
Law
and Regulation
Biomedical Ethics and Regulation
Publication details
- Journal / source
- Handchirurgie · Mikrochirurgie · Plastische Chirurgie
- Publisher
- Georg Thieme Verlag KG
- Volume
- 58
- Issue
- 04
- Pages
- 344–349
- Publication date
- 29 May 2026
- Language
- DE